Table 4 The proportion of treatment modalities (no transplantation vs transplantation) in different cytogenetic category, age group and disease subtypes
no transplantation | transplantation | ||
|---|---|---|---|
Cytogenetic category | Intermediate, n = 79 | 68.4% (54/79) | 31.6% (25/79) |
Unfavorable, n = 11 | 100% (11/11) | 0 (0/11) | |
Age group | <40, n = 54 | 59.3% (32/54) | 40.7% (22/54) |
40–60, n = 34 | 85.3% (29/34) | 14.7% (5/34) | |
>60, n = 9 | 100% (9/9) | 0 (0/9) | |
Subtypes | MDS, n = 65 | 70.8% (46/65) | 29.2% (19/65) |
AML, n = 32 | 75% (24/32) | 25% (8/32) | |